Mark Tometsko

5.4k total citations · 2 hit papers
18 papers, 4.3k citations indexed

About

Mark Tometsko is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Mark Tometsko has authored 18 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 12 papers in Molecular Biology and 6 papers in Cancer Research. Recurrent topics in Mark Tometsko's work include Bone Metabolism and Diseases (11 papers), Bone health and treatments (8 papers) and NF-κB Signaling Pathways (5 papers). Mark Tometsko is often cited by papers focused on Bone Metabolism and Diseases (11 papers), Bone health and treatments (8 papers) and NF-κB Signaling Pathways (5 papers). Mark Tometsko collaborates with scholars based in United States, France and Japan. Mark Tometsko's co-authors include William C. Dougall, David Cosman, Dirk Anderson, Laurent Galibert, Eugene Maraskovsky, Robert DuBose, Mark Teepe, Eileen R. Roux, Allison Armstrong and Moira Glaccum and has published in prestigious journals such as Nature, Journal of Biological Chemistry and Genes & Development.

In The Last Decade

Mark Tometsko

18 papers receiving 4.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function

1997 1.8k citations Dirk Anderson, Eugene Maraskovsky et al. Nature profile →
RANK is essential for osteoclast and lymph node development

1999 1.2k citations William C. Dougall, Moira Glaccum et al. Genes & Development profile →

Peers

Countries citing papers authored by Mark Tometsko

Since Specialization

Citations

This map shows the geographic impact of Mark Tometsko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Tometsko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Tometsko more than expected).

Fields of papers citing papers by Mark Tometsko

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Tometsko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Tometsko. The network helps show where Mark Tometsko may publish in the future.

Co-authorship network of co-authors of Mark Tometsko

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Tometsko. A scholar is included among the top collaborators of Mark Tometsko based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Tometsko. Mark Tometsko is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	Immune Microenvironment Analysis of Bone Marrow By Mass Cytometry and RNA Sequencing in Multiple Myeloma Patients Treated with Daratumumab and Durvalumab 2018 ·Blood ·(unknown), Mary H. Young, Mark Tometsko, Jamie Cavenagh, Ethan Thompson, Elizabeth Whalen, (unknown), Alison Fitch, Brian A. Fox, Andrew Dervan, (unknown), (unknown), John G. Gribben	2
2	Comprehensive Immune Profiling from Peripheral Blood and Bone Marrow in Newly Diagnosed and Relapsed/Refractory Multiple Myeloma Patients Reflects Differences in Immune Subsets and Activation Status 2018 ·Blood ·(unknown), Mark Tometsko, Wilbert B. Copeland, Elizabeth Whalen, Frank Schmitz, Ethan Thompson, Amit Agarwal, Teresa M. Foy, (unknown), Vitalina Komashko, (unknown), Brian A. Fox, Kathryn J. Newhall	3
3	Altering Antibody–Drug Conjugate Binding to the Neonatal Fc Receptor Impacts Efficacy and Tolerability 2016 ·Molecular Pharmaceutics ·Kevin J. Hamblett, Tiep Le, Brooke M. Rock, Dan A. Rock, Sophia Siu, (unknown), Kip P. Conner, Robert R. Milburn, Jason O’Neill, Mark Tometsko, William C. Fanslow	31
4	SLC46A3 Is Required to Transport Catabolites of Noncleavable Antibody Maytansine Conjugates from the Lysosome to the Cytoplasm 2015 ·Cancer Research ·Kevin J. Hamblett, Allison P. Jacob, Jesse L. Gurgel, Mark Tometsko, Brooke M. Rock, Sonal Patel, Robert R. Milburn, Sophia Siu, Seamus P. Ragan, Dan A. Rock, Christopher J. Borths, Jason O’Neill, Wesley Chang, Margaret F. Weidner, Matthew M. Bio, Kim Quon, William C. Fanslow	90
5	RANK and RANK ligand expression in primary human osteosarcoma 2015 ·Journal of bone oncology ·Daniel Branstetter, Kathy Rohrbach, Liya Huang, R Soriano, Mark Tometsko, Michelle Blake, Allison P. Jacob, William C. Dougall	41
6	Intracellular Catabolism of an Antibody Drug Conjugate with a Noncleavable Linker 2015 ·Drug Metabolism and Disposition ·Brooke M. Rock, Mark Tometsko, Sonal Patel, Kevin J. Hamblett, William C. Fanslow, Dan A. Rock	20
7	RANKL Inhibition Blocks Osteolytic Lesions and Reduces Skeletal Tumor Burden in Models of Non–Small-Cell Lung Cancer Bone Metastases 2014 ·Journal of Thoracic Oncology ·Robert E. Miller, Jon C. Jones, Mark Tometsko, Michelle Blake, William C. Dougall	33
8	RANK expression on breast cancer cells promotes skeletal metastasis 2013 ·Clinical & Experimental Metastasis ·Michelle Blake, Mark Tometsko, Robert E. Miller, Jon C. Jones, William C. Dougall	49
9	RANK Induces Epithelial–Mesenchymal Transition and Stemness in Human Mammary Epithelial Cells and Promotes Tumorigenesis and Metastasis 2012 ·Cancer Research ·Marta Palafox, Irene Ferrer, Pasquale Pellegrini, Sergi Vila, (unknown), Ander Urruticoechea, Fina Climent, (unknown), Purificacı́on Muñoz, Francesc Viñals, Mark Tometsko, Dan Branstetter, William C. Dougall, Eva González‐Suárez	153
10	P3-01-14: RANK and RANK Ligand (RANKL) Expression in Invasive Breast Carcinoma and Human Breast Cancer Cell Lines. 2011 ·Cancer Research ·Allison P. Jacob, Daniel Branstetter, Kathy Rohrbach, Aaron Winters, Ryan Erwert, (unknown), Jon C. Jones, Robert E. Miller, Mark Tometsko, Michelle Blake, (unknown)	4
11	Receptor activator of NF-kB (RANK) and RANK ligand protein expression in invasive ductal carcinoma. 2009 ·Cancer Research ·(unknown), Allison P. Jacob, Mark Tometsko, Ryan Erwert, (unknown), R Soriano, (unknown), Jennifer Hawkins, Daniel Branstetter, William C. Dougall	2
12	347 POSTER The RANK ligand inhibitor OPG-Fc reduces bone lesions and skeletal tumor burden in the MDA-231 breast cancer and PC3 prostate cancer experimental osteolytic metastases models 2006 ·European Journal of Cancer Supplements ·Richard T. Miller, Jennifer L. Jones, Mark Tometsko, Anne Armstrong, Jude Canon, Esther S. Trueblood, Martine P. Roudier, (unknown)	3
13	Osteoclast Differentiation Is Impaired in the Absence of Inhibitor of κB Kinase α 2004 ·Journal of Biological Chemistry ·Michelle Chaisson, Daniel Branstetter, Jonathan M.J. Derry, Allison Armstrong, Mark Tometsko, Kiyoshi Takeda, Shizuo Akira, William C. Dougall	76
14	A RANK/TRAF6-dependent Signal Transduction Pathway Is Essential for Osteoclast Cytoskeletal Organization and Resorptive Function 2002 ·Journal of Biological Chemistry ·Allison Armstrong, Mark Tometsko, Moira Glaccum, Claire L. Sutherland, David Cosman, William C. Dougall	199
15	RANK is essential for osteoclast and lymph node development breakdown → 1999 ·Genes & Development ·William C. Dougall, Moira Glaccum, K Charrier, Kathy Rohrbach, Kenneth Brasel, Thibaut De Smedt, Elizabeth Daro, J. A. Smith, Mark Tometsko, C R Maliszewski, Allison Armstrong, V. Shen, Steven D. Bain, David Cosman, Dirk Anderson, Philip Morrissey, Jacques J. Peschon, JoAnn C. L. Schuh	1154
16	The Involvement of Multiple Tumor Necrosis Factor Receptor (TNFR)-associated Factors in the Signaling Mechanisms of Receptor Activator of NF-κB, a Member of the TNFR Superfamily 1998 ·Journal of Biological Chemistry ·Laurent Galibert, Mark Tometsko, Dirk Anderson, David Cosman, William C. Dougall	273
17	A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function breakdown → 1997 ·Nature ·Dirk Anderson, Eugene Maraskovsky, (unknown), William C. Dougall, Mark Tometsko, Eileen R. Roux, Mark Teepe, Robert DuBose, David Cosman, Laurent Galibert	1824
18	Functional Characterization of the Human Interleukin-15 Receptor αChain and Close Linkage of IL15RA and IL2RA Genes 1995 ·Journal of Biological Chemistry ·Dirk Anderson, Satoru Kumaki, Minoo Ahdieh, (unknown), Mark Tometsko, A. Katrina Loomis, Judith G. Giri, Neal G. Copeland, Debra J. Gilbert, Nancy A. Jenkins, Virginia Valentine, David N. Shapiro, Stephan W. Morris, Linda Park, David Cosman	309

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact